SIGNACOXX Capsule by Dr Precision is a highly specialized selective COX-2 inhibitor NSAID designed for effective management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal conditions. Manufactured by Bluepill Express under stringent WHO-GMP and ISO-certified standards, this pharmaceutical-grade capsule ensures high purity and batch consistency. Its unique selectivity for COX-2 enzyme offers potent analgesic and anti-inflammatory effects while significantly reducing gastrointestinal side effects commonly seen with traditional NSAIDs. The encapsulation technology enables rapid dissolution and systemic availability, facilitating quick onset and sustained relief, thereby enhancing patient compliance. SIGNACOXX is ideal for long-term management of chronic inflammatory disorders and as a safe alternative for patients intolerant to non-selective NSAIDs. Available in blister strips or HDPE containers with comprehensive export documentation, it supports global distribution for hospital, pharmacy, and private label markets.
Key Features
| Features | Description |
|---|---|
| Selective COX-2 Inhibition | Targets COX-2 enzyme specifically reducing inflammation and pain with fewer gastrointestinal side effects |
| Indications | Osteoarthritis, Rheumatoid arthritis, Ankylosing spondylitis, Acute musculoskeletal pain, Postoperative pain |
| Manufacturing Standards | Produced under WHO-GMP and ISO-certified pharmaceutical plants |
| Gastrointestinal Safety | Minimizes gastric ulceration and bleeding risk compared to non-selective NSAIDs |
| Rapid Onset & Sustained Relief | Advanced encapsulation technology ensures quick systemic absorption and prolonged efficacy |
| Packaging Options | Available in blister strips and HDPE containers with export-compliant labeling |
| Quality Assurance | High purity APIs, batch-to-batch consistency, pharmacopoeial-grade materials |
| Global Compliance | Includes COA, MSDS, stability data, and product inserts tailored for export markets |
| Application | Suitable for hospital use, pharmacy chains, and private label branding |
| Provider | Third-party manufacturing and private labeling by Bluepill Express under Dr Precision |
| Attributes | Description |
|---|---|
| Drug Class | Selective COX-2 Inhibitor NSAID |
| Active Ingredient | High-purity COX-2 selective compound (exact API details proprietary) |
| Dosage Form | Capsule |
| Capsule Shell | Pharmaceutical-grade gelatin for rapid dissolution |
| Indications for Use | Chronic inflammatory and acute pain conditions |
| Packaging | Blister strips or HDPE containers with clear labeling |
| Manufacturing Compliance | WHO-GMP, ISO-certified facilities |
| Documentation | COA, MSDS, stability data, product insert |
| Target Market | Global distribution with regulatory compliance for exports |
| Manufacturer | Bluepill Express under Dr Precision label |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
SIGNACOXX Capsule selectively inhibits the COX-2 enzyme responsible for inflammation and pain without significantly affecting COX-1, which protects the gastric mucosa. This specificity reduces the risk of gastric ulcers, bleeding, and renal adverse effects often associated with non-selective NSAIDs.
Yes, due to its selective COX-2 inhibition and favorable gastrointestinal safety profile, SIGNACOXX Capsule is designed for long-term management of chronic inflammatory conditions such as osteoarthritis and rheumatoid arthritis.
SIGNACOXX Capsule is available in pharmaceutical-grade blister strips and HDPE containers, both compliant with international packaging standards and including export documentation such as COA, MSDS, and stability data.
Yes, Bluepill Express provides full regulatory support including customized product inserts, documentation, and batch traceability to ensure compliance with regulated global markets.
Absolutely. SIGNACOXX is offered through Bluepill Express's third-party manufacturing services with private labeling and customized packaging options tailored to client requirements.
Its selective COX-2 inhibition allows for effective pain and inflammation relief with a reduced side effect profile, especially fewer gastrointestinal complications, making it safer for acute musculoskeletal injury management.
Country Of Origin: India
SIGNACOXX Capsule is a selective COX-2 inhibitor formulated to provide effective relief from pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, and acute musculoskeletal disorders. Manufactured under strict international standards by Bluepill Express, it offers a gastrointestinal-safe alternative to traditional NSAIDs.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
SIGNACOXX Capsule is a specialized non-steroidal anti-inflammatory drug (NSAID) designed to manage pain and inflammation with enhanced selectivity for the cyclooxygenase-2 (COX-2) enzyme. The formulation is commonly used in the treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain caused by musculoskeletal injuries, dental procedures, and postoperative recovery. The capsule offers potent analgesic and anti-inflammatory action while minimizing gastrointestinal irritation often associated with conventional NSAIDs that inhibit both COX-1 and COX-2 enzymes.
The key advantage of SIGNACOXX lies in its selective COX-2 inhibition mechanism, which allows it to alleviate pain and inflammation without significantly affecting COX-1 activity, thereby reducing the risk of gastric ulcers, bleeding, and renal complications. This targeted action makes it an optimal choice for patients with chronic inflammatory conditions who require long-term pain management with a favorable gastrointestinal safety profile.
Manufactured by Bluepill Express, SIGNACOXX Capsule is produced under stringent quality controls in WHO-GMP and ISO-certified pharmaceutical plants. The product is developed using high-purity active pharmaceutical ingredients (APIs), advanced encapsulation technology, and internationally compliant packaging. Bluepill Express ensures batch-to-batch consistency, pharmacopoeial-grade materials, and export-standard documentation, making SIGNACOXX suitable for global distribution, including to regulated markets.
The formulation of SIGNACOXX provides rapid onset of action with sustained relief, enabling improved patient compliance and daily function restoration. It is often prescribed by rheumatologists, orthopedic surgeons, and pain management specialists as part of multi-modal therapy. Additionally, it serves as an effective alternative for patients intolerant to non-selective NSAIDs or those with a history of gastrointestinal disorders.
Each capsule is encased in a pharmaceutical-grade gelatin shell, designed for rapid dissolution and systemic availability. The packaging includes blister strips or HDPE containers with clear labeling for dosage guidance, batch traceability, and export documentation including COA, MSDS, stability data, and product inserts tailored for individual market compliance.
SIGNACOXX Capsule is offered through Bluepill Express’s third-party manufacturing solutions with full-service options including product development, private labeling, customized packaging, regulatory support, and global logistics. Whether for hospital supply, pharmacy chains, or private retail branding, the formulation is suitable for both acute prescriptions and long-term chronic care regimens.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
